Drugs / Trimethoprim/Sulfamethoxazole
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT01747278 | Aug 2012 → Jun 2013 | pneumocystosis | Peking Union Medical College Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trimethoprim/Sulfamethoxazole | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01747278 ↗ |
| Route | Oral | “Oral Trimethoprim/Sulfamethoxazole 80 mg/400mg once daily for 12 weeks.” NCT01747278 ↗ |